Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
118.2 USD | +1.10% | +1.23% | +9.76% |
May. 10 | Goldman Sachs Adjusts Price Target on T. Rowe Price Group to $110 From $112, Keeps Sell Rating | MT |
May. 10 | T. Rowe Price Group's Preliminary Assets Under Management Decline in April | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company has a low valuation given the cash flows generated by its activity.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- With an enterprise value anticipated at 3.3 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.76% | 26.11B | B | ||
-3.68% | 117B | A- | ||
+7.89% | 97.97B | C+ | ||
+15.16% | 68.65B | - | B+ | |
+21.20% | 64.23B | C | ||
+13.53% | 43.62B | C+ | ||
+16.10% | 43.12B | A- | ||
+21.85% | 35.88B | A- | ||
-2.67% | 22.54B | A- | ||
+4.51% | 19.08B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- TROW Stock
- Ratings T. Rowe Price Group Inc.